XRCC4 glutarylation increases sensitivity to PARP inhibitors in breast cancer by inhibiting mTOR activity and promoting autophagy

Xianqiang Du(Fujian Medical University), Qinglan Wang(Fujian Medical University), Chengye Hong(Fujian Medical University), Li Li(Sun Yat-sen University), Yuqiang Huang(Fujian Medical University), X L Yang(Fujian Medical University)
Research Square
June 8, 2026
Cited by 0


Related Papers